Seminars in Oncology
Volume 29, Issue 6 , Pages 563-574 , December 2002

Traditional Chinese medicine in the treatment of breast cancer

References 

  1. Eisenberg DM, Davis RB, Ettner SL, et al.  Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA. 1998;280:1569–1575
  2. Eisenberg DM, Kessler RC, Foster C, et al.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–252
  3. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer. Cancer. 1998;83:777–782
  4. Adler S. Complimentary and alternative medicine use among women with breast cancer. Med Anthropol Q. 1999;13:214–222
  5. Jacobson JS, Workman SB, Kronenberg F. Research on complementary/ alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol. 2000;18:668–683
  6. Tagliaferri M, Cohen I, Tripathy D. Complimentary and alternative medicine in early stage breast cancer. Semin Oncol. 2001;28:121–134
  7. Zhang DZ. The Treatment of Cancer by Integrated Chinese Western Medicine. In: Boulder, CO: Blue Poppy Press; 1989;p. 1–2
  8. Wu JN, trans . Ling Shu or The Spiritual Pivot. In: Washington, DC: The Taoist Center; 1993;p. 274; 274
  9. Fu QZ. Fu Qing Zhu's Gynecology (Yang S, Liu D, trans). In: Boulder, CO: Blue Poppy Press; 1992;p. 248–250 (1607- 1684 CE)
  10. Zhu DX. The Heart and Essence of Dan-xi's Methods of Treatment (Yang S, trans). In: Boulder, CO: Blue Poppy Press; 1993;p. 313–316 (1281- 1358 CE)
  11. Zhang DZ. The Treatment of Cancer by Integrated Chinese Western Medicine. In: Boulder, CO: Blue Poppy Press; 1989;p. 2–13
  12. Olayiwola A. WHO guidelines for the assessment of herbal medicines. In: ESCOP Symposium: The Scientific Assessment of Phytomedicines, Vol 1, XIII, No 2. Milan, Italy: Fitoterapia; March 13, 1992;
  13. Balandrin MF, Kjocke JA, Wurtele ES, et al.  Natural plant chemicals: sources of industrial and medicinal materials. Science. 1985;228:1154–1160
  14. O'Neil MJ, Lewis JA. The renaissance of plant research in the pharmaceutical industry. In:  Kinghorn AD,  Balandrin MF editor. Human Medicinal Agents From Plants. ACS Symposium Series 534. Washington, DC: American Chemical Society; 1993;p. 48–55
  15. Cragg GM, Newman DJ, Sander KM. Natural products in drug discovery and development. J Nat Prod. 1997;60:52–60
  16. Cragg GM, Schepartz SA, Suffness M, et al.  The Taxol supply crisis: New NCI policies for handling the large scale production of novel natural product anticancer and anti-HIV agents. J Nat Prod. 1993;56:1657–1668
  17. Boik J. Natural Compounds in Cancer Therapy. Princeton, MN: Oregon Medical Press; 2001;
  18. Campbell MJ, Hamilton B, Shoemaker M, et al.  Antiproliferative effects on breast cancer cells of some medicinal extracts used in traditional Chinese medicine. Proc Am Assoc Cancer Res. 2001;42:484; (abstr)
  19. Shi L, Shi P. Experience in Treating Carcinoma With Traditional Chinese Medicine. Shandong, China: Shandong Science and Technology Press; 1990;
  20. Xie W. Cancer = Death?: Treatment of Cancer the Chinese Way. Beijing, China: New World Press; 1997;
  21. Cheung CS. Breast cancer supportive management: A collective works from TCM practitioners of China. San Francisco, CA: Harmonious Sunshine Press; 1999;
  22. Zhou M, Wu YH, Liu YD. Integrated Chinese-Western medicine treatments for advanced stage breast cancer: An analysis of 14 cases. China Integrated Chin West Med J. 1996;15:237
  23. Yin XD. An analysis of 32 cases of breast cancer treated with combination of FACT and Kang Lai Te injection. Ji Lu Tumor J. 1999;6:158–159 (in Chinese)
  24. An analysis of 134 cases of breast cancer treated with Chinese-Western integrated medicine. Chin Med J (Beijing). 1985;13:111; Anonymous
  25. Lei QM, Song JS, Fan DN, et al.  Observations on 77 cases of breast cancer treated with the Chinese herb Teng Huang. Cancer Prev Res. 1986;13:111; (in Chinese)
  26. Yang GJ, Zhao L. Observations on the results of 216 cases of breast cancer treated with combined Chinese-Western medicine. Intermed Med Periodical. 1998;23:48–50 (in Chinese)
  27. Shen SY, Jiang CY. 14 cases of breast disease treated with a combination of Hai Zao and Gan Cao. Chinese Medical News. 1990;7:40–41 (in Chinese)
  28. Wang Q, He SJ. 31 cases of breast cancer treated with integrated Chinese-Western medicine. Cancer. 1990;9:238; (in Chinese)
  29. Guo T, Xu B, Yan SQ, et al.  Neoadjuvant Chemotherapy of Advanced Breast Cancer (stage III). Shandong, China: Qingdao Tumor Hospital; 2000; (in Chinese)
  30. Niu DL, et al.  Curative observation on effects of Chinese herbs and western drugs applied to quench vomiting caused by tumor chemotherapy. Ch J Integ Trad Chin Med West Med. 1995;15:397
  31. Liu M, Yao M, Shen P. Personal Experience in Herbal Treatment of Postoperative Breast Cancer (Li PP, trans). Shanghai, China: Affiliated Longhua Hospital, Shanghai College of TCM; 1996;
  32. Fan C. 30 Cases of Breast Cancer Treated by Herbal Medicines During Chemotherapy After Surgery. (Li PP, trans, Beijing Medical Institute, Beijing, China) 1996;
  33. Li P, Wang X, Yu R, et al.  A Study of Breast Cancer Due to Mental Depression (Li PP, trans). Beijing, China: Beijing TCM Hospital; 1996;
  34. Liu S. Lu Deming's Experience in Treatment of Advanced Metastatic Breast Cancer. (Li PP, trans, Beijing Medical Institute, Beijing, China) 1996;
  35. Ni M, trans . The Yellow Emperror's Classic of Medicine. In: Boston, MA: Shambhala; 1995;p. 1–4
  36. Gao YT: Implications of the time trend of cancer incidence in urban Shanghai, China, for cancer. www.who.int/ncd/cancer/publications/abstracts
  37. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33–64
  38. Greenwald P. Experience from clinical trials in cancer prevention. Ann Med. 1994;26:73–80
  39. Nakachi K, Suemasu K, Suga K, et al.  Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89:254–261
  40. Dupont W, Page D. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–151
  41. Haagansen CD. Diseases of the Breast. ed 2. Philadelphia, PA: Saunders; 1971;
  42. Chardot C, Varroy A, Parache RM. Fibro-cystic mastosis and cancer (206 cases of mastosis in possible relation with 12 cases of cancer). Bull Cancer. 1970;57:251–268
  43. Roberts MM, Jones V, Elton RA, et al.  Risk of breast cancer in women with history of benign disease of the breast. Br Med J (Clin Res Ed). 1984;288:275–278
  44. Bundred NJ, West RR, O'Dowd J, et al.  Is there an increased risk of breast cancer in women who have a breast cyst aspirated?. Br J Cancer. 1991;64:953–955
  45. Bruzzi P, Dogliotti L, Naldoni C, et al.  Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. Br Med J. 1997;314:925–928
  46. Dixon JM, McDonald C, Elton RA, et al.  Risk of breast cancer in women with palpable breast cysts: A prospective study. Edinburgh Breast Group. Lancet. 1999;353:1742–1745
  47. Flaws B, Chace C. Recent TCM Research From China—1991-1994. In: Boulder, CO: Blue Poppy Press; 1994;p. 86–99
  48. Ye X, Zhang G. Clinical experience in the treatment of 120 cases of mammary neoplasia with ru tong ling (breast pain efficacious remedy). Tianjin J TCM. 1994;3:6
  49. Tan J, Feng Y. Analysis on 96 cases of masto-hyperplasia treated by point-injection. Chin Acupuncture Moxibustion. 1996;7:27–28
  50. Han J. Central neurotransmitters and acupuncture analgesia. In:  Pomeranz B,  Stux G editor. Scientific Basis of Acupuncture. New York, NY: Springer-Verlag; 1989;p. 7–33
  51. Mandelson MT, Oestreicher N, Porter PL, et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–1087
  52. Boyd NF, Byng JW, Jong RA, et al.  Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87:670–675
  53. Yin K. Observation on curative effect of xiao he ling applied to treat 460 patients of mastoplasia. Gansu J TCM. 1995;8:30–31
  54. Li PP, Yu GQ, President Emeritus of All China Society of Cancer Prevention and Treatment With Integrated TCM and WM, personal communication, Nov 3, 1998
  55. Pan M. Cancer Treatment with Fu Zheng Pei Ben Principle. In: Fujian, China: Fujian Science and Technology; 1992;p. 225–238
  56. Yu G, Liang F, Zhang D. The combined TCM-WM prevention and treatment of malignant tumor marching towards 21st century. In: International Conference on Prevention and Treatment of Cancer With TCM-WM. Nov 3-6, 1998;p. 171
  57. Zhang D. Preventing and treating side-effects by chemo- and/or radiotherapy over the past 40 years. In: International Conference on Prevention and Treatment of Cancer With TCM- WM. 1998;p. 174
  58. Liu M, Yao M, Shen P. Personal experience in herbal treatment of post-operative breast cancer. Shanghai, China: Affiliated Longhua Hospital, Shanghai College of TCM; 1991;
  59. Wang G, Zhao L. Observation on the results of 216 cases of breast cancer treated with integrated Chinese-Western medicine. Intermed Med Periodical [Zhong Ji Yi Kan]. 1988;23:48–50
  60. Chinese Medicine Research Institute, Guang An Men Hospital Oncology Department . An analysis of 134 cases of breast cancer treated with Chinese-Western integrated medicine. Chin Med J [Zhong Yi Zha Zhi]. 1985;13:111–113
  61. Yin X, Liu S, Tong J-D, et al.  An analysis of 32 cases of breast cancer treated with a combination of FACT and Kang Lai Te injection. Qilu J Oncol [Qi Lu Zhong Liu Za Zhi]. 1999;6:158–159
  62. Rose DP, Connolly JM, Rayburn J, et al.  Influence of diets containing eicosapentaenoic acid or docosaheaenoic acid on growth and metastases of breast cancer cells in nude mice. J Natl Cancer Inst. 1995;87:587–592
  63. Yang H, Wang X, Yu L, et al.  Effects of Kang Lai Te (KLT) injection on cell proliferation kinetics and modulation of doxorubicin resistance. In: Zhejiang, China: Kang Lai Te Injection: Pharmacology and Clinical Application, Cancer Institute, Zhejiang Medical University; 1999;p. 363–366
  64. Han R. Developments in research on anti-cancer Chinese herbs. China New Herbs J. 1993;2:1–7
  65. Lei Q, Song Q, Fa D-N, et al.  Observations on 77 cases of breast cancer treated with the Chinese herb Teng Huang. Cancer Prev Res [Zhong Liu Fang Zhi Yan Jui]. 1986;13:111
  66. Vickers A, Goyal N, Harland R, et al.  Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clin Trials. 1998;19:159–166
  67. Tang J, Zhan S, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. Br Med J. 1999;319:160–161
  68. Slamon DJ, Leyland-Jones B, Shak S, et al.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344:783–792
  69. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134–138

☆ Supported in part by NIH/NCI P50 CA 58207.

☆☆ Address reprint requests to Debu Tripathy, MD, Department of Medicine and Cancer Center, Carol Franc Buck Breast Care Center, University of California at San Francisco, San Francisco, CA 94143-1714.

PII: S0093-7754(02)50319-5

doi: 10.1053/sonc.2002.50005

Seminars in Oncology
Volume 29, Issue 6 , Pages 563-574 , December 2002

Article Tools